期刊文献+

SEMA3F蛋白在肝细胞癌中的表达及其预后价值 被引量:2

Expression and prognostic value of SEMA3F protein in hepatocelluar carcinoma
原文传递
导出
摘要 目的研究SEMA3F蛋白在肝细胞癌(hepatocelluarcarcinoma,HCC)中的表达及其预后价值。方法采用WesternBlotting法检测32例HCC及相应癌旁肝组织标本中SEMA3F蛋白的表达。运用免疫组织化学法检测38例HCC以及其相应癌旁组织中的SEMA3F蛋白的表达和微血管密度(microvasseldainty,MVD)值,分析SEMA3F蛋白表达水平与MVD的相关性。结果SEMA3F蛋白在32例HcC组织中的表达明显低于相应的PCLT(447.78±48.26比618.93±61.23,P〈0.05)。SEMA3F在HCC组织中的表达水平与肿瘤的结节数目及是否具有包膜结构密切相关(P〈0.05)。SEMA3F低表达组的复发转移率显著高于高表达组(P〈0.01)而其术后生存率则显著低于高表达组(P〈0.01)。SEMA3F高表达组的MVD值明显低于低表达组(86.56±17.94比115.6±30.38,P〈0.01)。结论sEMA3F在HCC组织中表达下调与肝癌复发转移率高和预后差密切相关,提示其可能是一个潜在的HCC预后分子标志物。 Objective To investigate the expression of Semaphorin 3F (SEMA3F) protein in hepatocellular carcinoma (HCC) and to demonstrate its relationship with clinicopathological features and prognosis of HCC, Methods Western Blotting was carried out in 32 hepatocellular carcinoma samples and matched perineoplastic tissues to detect the expression of SEMA3F protein. The relationship between SEMA3F protein expression and clinicopathological features as well as prognosis of HCC patients was analyzed. Immunohistochemistry was used to show the location of SEMA3F in HCC cells and its relationship with microvessel density (MVD). Results The expression of SEMA3F protein in HCC tissues was significantly higher than in the perineoplastic tissues (447.78 ± 48.26 vs 618.93 ± 61.23, P〈0. 05) and it was correlated closely with tumor capsulation and tumor nodular number (P〈0. 05). Based on the Western Blotting and clinical follow-up data, we found that the survival time of HCC patients with a higher SEMA3F expression level was longer than those with a lower level, and the recurrent/metastatic time of HCC patients was significantly different between these two groups (P〈0. 01). Immunohistochemistry demonstrated that SEMA3F protein localized in the cytoplasm of HCC cells and its expression correlated with HCC MVD. MVD in the low-level group was higher than the high-level group (115.6±30.38 vs 86.56±17.94, P〈0.01). Conclusions SEMA3F expression in HCC was significantly down-regulated and correlated closely with tumor-capsulation, nodular number, and MVD, implicating SEMA3F may play an important role in recurrence and metastasis of HCC. It can be regarded as a prognostic marker in HCC patients.
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2011年第3期219-222,共4页 Chinese Journal of Hepatobiliary Surgery
基金 基金项目:国家“十五”科技攻关项目(2001BA703804) 国家重点基础研究发展计划-973计划(2004CB720303)
关键词 肝细胞癌 SEMA3F 复发转移 预后 Hepatocellular carcinoma Semaphorin 3F Recurrence/metastasis Prognosis
  • 相关文献

参考文献5

二级参考文献42

  • 1文卫,杨连粤,黄耿文,杨治力,刘合利,杨建青.TSP-1和VEGF在肝细胞癌新生血管生成中的作用[J].中华肝胆外科杂志,2005,11(1):17-19. 被引量:19
  • 2[1] Tanaka A, Morimoto T, Ozaki N, et al. Extension of surgical indication for advanced hepatocellular carcinoma. Hepatogastroenterol, 1996, 43::1172-1181.
  • 3[2] Lee NH, Chau GY, Lui WY, et al. Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10cm in diameter. Br J Surg, 1998, 85:1654-1657.
  • 4[3] Nagasue N, Kohno H, Tachibana M, et al. Prognostic factors after hepatic resection for hepatocellular carcinoma associated with Child-Turcotte class B and C cirrhosis. Ann Surg, 1999, 229:84-90.
  • 5[4] Poon RTP, Fan ST, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 2000, 232:10-24.
  • 6Parkin DM,Bray F,Ferlay J.Global cancer statistics.CA Cancer J Clin,2005,55:74-108.
  • 7Zhao YM,Wang L.Advancement of the relationship between vascular endothelial growth factor receptors and ansiogenesis of hepatocellular carcinoma.Shijie Huaren Xiaohua Zazhi,2007,15:596-600.
  • 8Folkman J.Isolation of a Tumor Factor Responsible to Anglogenesis.J Exp Med,1971,133:275-288.
  • 9Hanahan D,Folkman J.Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.Cell,1996,86:353.
  • 10Toi M,Matsumoto T,Bando H.Vascular endothelial growth factor:its prognostic,and therapeutic implications.Lancet Oncol,2003,2:667-673.

共引文献49

同被引文献23

  • 1Wang W,Xu GL,Jia WD,et al.Ligation of TLR2 by versican:a link between inflammation and metastasis[J]. Arch Med Res,2009,40:321-323.
  • 2Du WW,Yang BB,Shatseva TA,et al.Versican G3 promotes mouse mammary tumor cell growth,migration,and metastasis by influencing EGF receptor signaling[J].PLoS One,2010,5:e13828.
  • 3Ju H,Lim B,Kim M,et al.Genetic variants A1826H and D2937Y in GAG-beta domain of versican influence susceptibili ty to intestinal-type gastric cancer[J].J Cancer Res Clin On col,2010,136:195-201.
  • 4Kischel P,Waltregny D,Dumont B,et al.Versican overex pression in human breast cancer lesions:known and new iso forms for stromal tumor targeting[J]. Int J Cancer,2010,126:640-650.
  • 5Ricciardelli C,Sakko AJ,Ween MP,et al.The biological role and regulation of versican levels in cancer[J].Cancer Metasta sis Rev,2009,28:233-245.
  • 6Kim S,Takahashi H,Lin WW,et al.Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate me tastasis[J].Nature,2009,457:102-106.
  • 7Domenzain Reyna C,Hernández D,Miquel Serra L,et al.Structure and regulation of the versican promoter:the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells[J].J Biol Chem,2009,284:12306-12317.
  • 8Wu F, Zhou Q, Yang J, et al. Endogenousax on guiding che- morepulsant sernaphorin-3F inhibits the growth and metastasis of coloreetal carcinoma [J]. Clin Cancer Res, 2011, 17(9): 2702-2711.
  • 9Staton CA. Class 3 semaphorins and their receptors in physiological and pathological angiogenesis[J]. Biochem Sac Trans, 2011, 39(6) : 1565-1570.
  • 10Staton CA,Shaw LA, Valluru M, et al. Expression of class 3 sema- phorins and their receptors in human breast neoplasia[J]. Histopa- thology, 2011, 59(2):274-282.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部